{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/272088338"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The guidance explains how different types of amendments may affect the application???s original review dates, as well as FDA???s performance metric goals based on the different amendment Tiers and the process for submitting amendments." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pharmtech.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/409432663"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/272088338"] } } }
